Prostate-specific antigen (PSA) screening in asymptomatic men
Slaughter P, Pinfold P, Laupacis A
Record ID 32002000811
English
Authors' objectives:
This report aims to review the current evidence about the effectiveness of screening for prostate cancer in asymptomatic men, using the prostate-specific antigen (PSA) blood test.
Authors' recommendations:
The potential for over-treatment of some prostate cancers not destined to cause future mortality, the uncertainty about the benefits of aggressive treatment of screen-detected cancers, the lack of evidence from RCTs of the effectiveness of PSA screening, and the relatively high costs of prostate cancer screening programs combine to suggest that a programe of PSA screening of asymptomatic men should not be introduced at this time. This decision should be constantly revisited as new information becomes available, especially that from ongoing randomized trials.
Authors' methods:
Systematic review
Details
Project Status:
Completed
URL for project:
http://www.ices.on.ca/file/Prostate-specific%20Antigen%20(PSA)%20screening%20in%20asymptomatic%20men.pdf
Year Published:
2002
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
Canada
MeSH Terms
- Mass Screening
- Prostate-Specific Antigen
- Prostatic Neoplasms
Contact
Organisation Name:
Institute for Clinical Evaluative Sciences
Contact Address:
Institute for Clinical Evaluative Sciences, 2075 Bayview Avenue, G-Wing, Toronto ON, Canada, M5N 3M5. Tel: 416-480-4055; Fax: 416-480-6048
Contact Name:
info@ices.on.ca
Contact Email:
info@ices.on.ca
Copyright:
Institute for Clinical Evaluative Sciences (ICES)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.